|
1
|
Kros JM: Grading of gliomas: The road from
eminence to evidence. J Neuropathol Exp Neurol. 70:101–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Holland EC and Cairncross JG:
Glioma classification: A molecular reappraisal. Am J Pathol.
159:779–786. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suryadevara CM, Verla T, Sanchez-Perez L,
Reap EA, Choi BD, Fecci PE and Sampson JH: Immunotherapy for
malignant glioma. Surg Neurol Int. 6 Suppl 1:S68–S77. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jovcevska I, Kocevar N and Komel R: Glioma
and glioblastoma-how much do we (not) know? Mol Clin Oncol.
1:935–941. 2013.PubMed/NCBI
|
|
6
|
Ohgaki H: Genetic pathways to
glioblastomas. Neuropathology. 25:1–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhong Z, Wen Z and Darnell JE Jr: Stat3: A
STAT family member activated by tyrosine phosphorylation in
response to epidermal growth factor and interleukin-6. Science.
264:95–98. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rahaman SO, Vogelbaum MA and Haque SJ:
Aberrant Stat3 signaling by interleukin-4 in malignant glioma
cells: Involvement of IL-13Ralpha2. Cancer Res. 65:2956–2963. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Q, Li G, Li R, Shen J, He Q, Deng L,
Zhang C and Zhang J: IL-6 promotion of glioblastoma cell invasion
and angiogenesis in U251 and T98G cell lines. J Neurooncol.
100:165–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jackson C, Ruzevick J, Amin AG and Lim M:
Potential role for STAT3 inhibitors in glioblastoma. Neurosurg Clin
N Am. 23:379–389. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnston PA and Grandis JR: STAT3
signaling: Anticancer strategies and challenges. Mol Interv.
11:18–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
See AP, Han JE, Phallen J, Binder Z,
Gallia G, Pan F, Jinasena D, Jackson C, Belcaid Z, Jeong SJ, et al:
The role of STAT3 activation in modulating the immune
microenvironment of GBM. J Neurooncol. 110:359–368. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carro MS, Lim WK, Alvarez MJ, Bollo RJ,
Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, et al:
The transcriptional network for mesenchymal transformation of brain
tumours. Nature. 463:318–325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luwor RB, Stylli SS and Kaye AH: The role
of Stat3 in glioblastoma multiforme. J Clin Neurosci. 20:907–911.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizoguchi M, Betensky RA, Batchelor TT,
Bernay DC, Louis DN and Nutt CL: Activation of STAT3, MAPK and AKT
in malignant astrocytic gliomas: Correlation with EGFR status,
tumor grade, and survival. J Neuropathol Exp Neurol. 65:1181–1188.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abou-Ghazal M, Yang DS, Qiao W,
Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W,
Sawaya R and Heimberger AB: The incidence, correlation with
tumor-infiltrating inflammation and prognosis of phosphorylated
STAT3 expression in human gliomas. Clin Cancer Res. 14:8228–8235.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Levy DE and Darnell JE Jr: Stats:
Transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dinasarapu AR, Gupta S, Ram Maurya M, Fahy
E, Min J, Sud M, Gersten MJ, Glass CK and Subramaniam S: A combined
omics study on activated macrophages-enhanced role of STATs in
apoptosis, immunity and lipid metabolism. Bioinformatics.
29:2735–2743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chung CD, Liao J, Liu B, Rao X, Jay P,
Berta P and Shuai K: Specific inhibition of Stat3 signal
transduction by PIAS3. Science. 278:1803–1805. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shuai K: Regulation of cytokine signaling
pathways by PIAS proteins. Cell Res. 16:196–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou H, Miki R, Eeva M, Fike FM, Seligson
D, Yang L, Yoshimura A, Teitell MA, Jamieson CA and Cacalano NA:
Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to
ionizing radiation in glioblastoma multiforme. Clin Cancer Res.
13:2344–2353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim DJ, Tremblay ML and Digiovanni J:
Protein tyrosine phosphatases, TC-PTP, SHP1 and SHP2, cooperate in
rapid dephosphorylation of Stat3 in keratinocytes following UVB
irradiation. PloS One. 5:e102902010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Funato K, Yamazumi Y, Oda T and Akiyama T:
Tyrosine phosphatase PTPRD suppresses colon cancer cell migration
in coordination with CD44. Exp Ther Med. 2:457–463. 2011.PubMed/NCBI
|
|
24
|
Bixler SL, Sandler NG, Douek DC and
Mattapallil JJ: Suppressed Th17 levels correlate with elevated
PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute
simian immunodeficiency virus infection. J Virol. 87:7093–7101.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brantley EC, Nabors LB, Gillespie GY, Choi
YH, Palmer CA, Harrison K, Roarty K and Benveniste EN: Loss of
protein inhibitors of activated STAT-3 expression in glioblastoma
multiforme tumors: Implications for STAT-3 activation and gene
expression. Clin Cancer Res. 14:4694–4704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Sun Y, Kong QY, Zhang KL, Wang XW,
Chen XY, Wang Q and Liu J: Combination of nucleic acid and protein
isolation with tissue array construction: Using defined histologic
regions in single frozen tissue blocks for multiple research
purposes. Int J Mol Med. 12:299–304. 2003.PubMed/NCBI
|
|
27
|
Li H, Guo L, Li JW, Liu N, Qi R and Liu J:
Expression of hyaluronan receptors CD44 and RHAMM in stomach
cancers: Relevance with tumor progression. Int J Oncol. 17:927–932.
2000.PubMed/NCBI
|
|
28
|
Ma JX, Li H, Chen XM, Yang XH, Wang Q, Wu
ML, Kong QY, Li ZX and Liu J: Expression patterns and potential
roles of SIRT1 in human medulloblastoma cells in vivo and in vitro.
Neuropathology. 33:7–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bralten LB and French PJ: Genetic
alterations in glioma. Cancers. 3:1129–1140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshida J: Molecular neurosurgery using
gene therapy to treat malignant glioma. Nagoya J Med Sci.
59:97–105. 1996.PubMed/NCBI
|
|
31
|
Xia SL, Wu ML, Li H, Wang JH, Chen NN,
Chen XY, Kong QY, Sun Z and Liu J: CRABP-II- and FABP5-independent
responsiveness of human glioblastoma cells to all-trans retinoic
acid. Oncotarget. 6:5889–5902. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lo HW, Cao X, Zhu H and Ali-Osman F:
Constitutively activated STAT3 frequently coexpresses with
epidermal growth factor receptor in high-grade gliomas and
targeting STAT3 sensitizes them to Iressa and alkylators. Clin
Cancer Res. 14:6042–6054. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schaefer LK, Ren Z, Fuller GN and Schaefer
TS: Constitutive activation of Stat3alpha in brain tumors:
Localization to tumor endothelial cells and activation by the
endothelial tyrosine kinase receptor (VEGFR-2). Oncogene.
21:2058–2065. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
O'Shea JJ, Schwartz DM, Villarino AV,
Gadina M, McInnes IB and Laurence A: The JAK-STAT pathway: Impact
on human disease and therapeutic intervention. Annu Rev Med.
66:311–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shu XH, Li H, Sun XX, Wang Q, Sun Z, Wu
ML, Chen XY, Li C, Kong QY and Liu J: Metabolic patterns and
biotransformation activities of resveratrol in human glioblastoma
cells: Relevance with therapeutic efficacies. PloS One.
6:e274842011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tamiya T, Kashiwagi I, Takahashi R,
Yasukawa H and Yoshimura A: Suppressors of cytokine signaling
(SOCS) proteins and JAK/STAT pathways: Regulation of T-cell
inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol.
31:980–985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sutherland KD, Lindeman GJ, Choong DY,
Wittlin S, Brentzell L, Phillips W, Campbell IG and Visvader JE:
Differential hypermethylation of SOCS genes in ovarian and breast
carcinomas. Oncogene. 23:7726–7733. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Martini M, Pallini R, Luongo G, Cenci T,
Lucantoni C and Larocca LM: Prognostic relevance of SOCS3
hypermethylation in patients with glioblastoma multiforme. Int J
Cancer. 123:2955–2960. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lindemann C, Hackmann O, Delic S, Schmidt
N, Reifenberger G and Riemenschneider MJ: SOCS3 promoter
methylation is mutually exclusive to EGFR amplification in gliomas
and promotes glioma cell invasion through STAT3 and FAK activation.
Acta Neuropathol. 122:241–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Feng GS: Shp2-mediated molecular signaling
in control of embryonic stem cell self-renewal and differentiation.
Cell Res. 17:37–41. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rakesh K and Agrawal DK: Controlling
cytokine signaling by constitutive inhibitors. Biochem Pharmacol.
70:649–657. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Furcht CM, Buonato JM, Skuli N, Mathew LK,
Muñoz Rojas AR, Simon MC and Lazzara MJ: Multivariate signaling
regulation by SHP2 differentially controls proliferation and
therapeutic response in glioma cells. J Cell Sci. 127:3555–3567.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sturla LM, Zinn PO, Ng K, Nitta M, Kozono
D, Chen CC and Kasper EM: Src homology domain-containing
phosphatase 2 suppresses cellular senescence in glioblastoma. Br J
Cancer. 105:1235–1243. 2011. View Article : Google Scholar : PubMed/NCBI
|
